Myograf (filgrastim biosimilar) / Amgen - LARVOL DELTA

Contractile myografts confer systemic anti-aging benefits. (PubMed, Nat Aging) - "In addition, myografts provide a stable source of virally transduced therapeutic proteins, such as parathyroid hormone and growth hormone, which may counteract bone or muscle loss without observed side effects. This approach opens a path for the application of cell and gene therapy in the treatment of diseases of aging."

Journal • Gene Therapies • Obesity • Transplantation

Contracting myografts mimic exercise response. (PubMed, Nat Aging) - No abstract available

Journal

Clinical safety evaluation and preliminary efficacy study of subcutaneous myografts transplantation (ChiCTR) - P=N/A | N=6 | Sponsor: National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation-Binhai Yangshi Orthopedic Hospital; National Clinical Research

New trial • Transplantation • IGF1

Clinical Safety Evaluation and Preliminary Efficacy Study of Subcutaneous Myografts Transplantation (clinicaltrials.gov) - P1 | N=6 | Not yet recruiting | Sponsor: National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China

New P1 trial • Metabolic Disorders • Transplantation